Viewing Study NCT07370766


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-26 @ 3:15 PM
Study NCT ID: NCT07370766
Status: RECRUITING
Last Update Posted: 2026-01-27
First Post: 2026-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Sponsor: Chronicle Academy
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module